Miguel V, Shaw IW, Kramann R (2025) Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol 21(1):39–56. https://doi.org/10.1038/s41581-024-00889-z

Bobulescu IA (2010) Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 19(4):393–402. https://doi.org/10.1097/MNH.0b013e32833aa4ac

Su H, Wan C, Lei CT, Zhang CY, Ye C, Tang H, Qiu Y, Zhang C (2018) Lipid deposition in kidney diseases: interplay among redox, lipid mediators, and renal impairment. Antioxid Redox Signal 28(10):1027–1043. https://doi.org/10.1089/ars.2017.7066

Mitrofanova A, Merscher S, Fornoni A (2023) Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol 19(10):629–645. https://doi.org/10.1038/s41581-023-00741-w

Opazo-Rios L, Mas S, Marin-Royo G, Mezzano S, Gomez-Guerrero C, Moreno JA, Egido J (2020) Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. https://doi.org/10.3390/ijms21072632

Article  PubMed  PubMed Central  Google Scholar 

Bhargava P, Schnellmann RG (2017) Mitochondrial energetics in the kidney. Nat Rev Nephrol 13(10):629–646. https://doi.org/10.1038/nrneph.2017.107

Gewin LS (2021) Sugar or fat? Renal tubular metabolism reviewed in health and disease. Nutrients. https://doi.org/10.3390/nu13051580

Article  PubMed  PubMed Central  Google Scholar 

Ouali F, Djouadi F, Merlet-Benichou C, Bastin J (1998) Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney. Am J Physiol-Renal Physiol 275(5):F777-784. https://doi.org/10.1152/ajprenal.1998.275.5.F777

Tovar-Palacio C, Torres N, Diaz-Villasenor A, Tovar AR (2012) The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr 7(4):483–498. https://doi.org/10.1007/s12263-012-0295-5

Yokoi H, Yanagita M (2016) Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease. Kidney Int 89(4):740–742. https://doi.org/10.1016/j.kint.2016.01.009

Khan S, Gaivin R, Abramovich C, Boylan M, Calles J, Schelling JR (2020) Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression. JCI Insight. https://doi.org/10.1172/jci.insight.136845

Article  PubMed  PubMed Central  Google Scholar 

Decleves AE, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, Le TP, Nortier JL, Farquhar MG, Naviaux RK, Sharma K (2014) Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int 85(3):611–623. https://doi.org/10.1038/ki.2013.462

Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U (2014) Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res 55(3):561–572. https://doi.org/10.1194/jlr.P040501

Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstadt H, Kerjaschki D, Mizushima N, Shaw AS, Walz G, Huber TB (2010) Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120(4):1084–1096. https://doi.org/10.1172/JCI39492

Merscher S, Fornoni A (2014) Podocyte pathology and nephropathy - sphingolipids in glomerular diseases. Front Endocrinol (Lausanne) 5:127. https://doi.org/10.3389/fendo.2014.00127

Martin-Fernandez B, Rubio-Navarro A, Cortegano I, Ballesteros S, Alia M, Cannata-Ortiz P, Olivares-Alvaro E, Egido J, de Andres B, Gaspar ML, de Las Heras N, Lahera V, Moreno JA (2016) Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats. PLoS One 11(1):e0145946. https://doi.org/10.1371/journal.pone.0145946

Article  PubMed  PubMed Central  Google Scholar 

Srivastava SP, Zhou H, Setia O, Dardik A, Fernandez-Hernando C, Goodwin J (2021) Podocyte glucocorticoid receptors are essential for glomerular endothelial cell homeostasis in diabetes mellitus. J Am Heart Assoc 10(15):e019437. https://doi.org/10.1161/JAHA.120.019437

Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, Gratton E, Parks J, Tontonoz P (2015) LXrs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife 4:e08009. https://doi.org/10.7554/eLife.08009

Luo J, Yang H, Song BL (2020) Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol 21(4):225–245. https://doi.org/10.1038/s41580-019-0190-7

Pan X (2022) Cholesterol metabolism in chronic kidney disease: physiology, pathologic mechanisms, and treatment. Adv Exp Med Biol 1372:119–143. https://doi.org/10.1007/978-981-19-0394-6_9

Liu X, Ducasa GM, Mallela SK, Kim JJ, Molina J, Mitrofanova A, Wilbon SS, Ge M, Fontanella A, Pedigo C, Santos JV, Nelson RG, Drexler Y, Contreras G, Al-Ali H, Merscher S, Fornoni A (2020) Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome. Kidney Int 98(5):1275–1285. https://doi.org/10.1016/j.kint.2020.06.040

Wahl P, Ducasa GM, Fornoni A (2016) Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol 310(6):F433-445. https://doi.org/10.1152/ajprenal.00375.2015

Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392(10159):2052–2090. https://doi.org/10.1016/S0140-6736(18)31694-5

Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, Nangaku M, Rodriguez-Iturbe B, Anders HJ (2025) Chronic kidney disease. Nat Rev Dis Primers 11(1):8. https://doi.org/10.1038/s41572-024-00589-9

Article  PubMed  Google Scholar 

Djudjaj S, Boor P (2019) Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 65:16–36. https://doi.org/10.1016/j.mam.2018.06.002

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305. https://doi.org/10.1056/NEJMoa041031

Douglas CE, Roem J, Flynn JT, Furth SL, Warady BA, Halbach SM, chronic kidney disease in children study I (2023) Effect of age on hypertension recognition in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension 80(5):1048–1056. https://doi.org/10.1161/HYPERTENSIONAHA.122.20354

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmer BF, Clegg DJ (2024) Hyperkalemia treatment standard. Nephrol Dial Transplant 39(7):1097–1104. https://doi.org/10.1093/ndt/gfae056

Raphael KL (2018) Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol 29(2):376–382. https://doi.org/10.1681/ASN.2017040422

Steiger S, Rossaint J, Zarbock A, Anders HJ (2022) Secondary immunodeficiency related to kidney disease (SIDKD)-definition, unmet need, and mechanisms. J Am Soc Nephrol 33(2):259–278. https://doi.org/10.1681/ASN.2021091257

Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G, collaborators CA (2024) Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: a literature systematic review. Pharmacol Res 203:107146. https://doi.org/10.1016/j.phrs.2024.107146

Article  CAS  PubMed  Google Scholar 

Strazzella A, Ossoli A, Calabresi L (2021) High-density lipoproteins and the kidney. Cells. https://doi.org/10.3390/cells10040764

Article  PubMed  PubMed Central  Google Scholar 

Schelling JR (2022) The contribution of lipotoxicity to diabetic kidney disease. Cells. https://doi.org/10.3390/cells11203236

Article  PubMed  PubMed Central  Google Scholar 

Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, Lewis GF, Lichtenstein AH, Moulin P, Nordestgaard BG, Remaley AT, Staels B, Stroes ESG, Taskinen MR, Tokgozoglu LS, Tybjaerg-Hansen A, Stock JK, Catapano AL (2021) Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J 42(47):4791–4806. https://doi.org/10.1093/eurheartj/ehab551

Bahiru E, Hsiao R, Phillipson D, Watson KE (2021) Mechanisms and treatment of dyslipidemia in diabetes. Curr Cardiol Rep 23(4):26. https://doi.org/10.1007/s11886-021-01455-w

Article  PubMed  Google Scholar 

Riedel MJ, Light PE (2005) Saturated and cis/trans unsaturated acyl CoA esters differentially regulate wild-type and polymorphic beta-cell ATP-sensitive K+ channels. Diabetes 54(7):2070–2079. https://doi.org/10.2337/diabetes.54.7.2070

Riedel MJ, Baczko I, Searle GJ, Webster N, Fercho M, Jones L, Lang J, Lytton J, Dyck JR, Light PE (2006) Metabolic regulation of sodium-calcium exchange by intracellular acyl CoAs. EMBO J 25(19):4605–4614. https://doi.org/10.1038/sj.emboj.7601321

Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37(8):1020–1024. https://doi.org/10.2337/diab.37.8.1020

Afshinnia F, Rajendiran TM, Soni T, Byun J, Wernisch S, Sas KM, Hawkins J, Bellovich K, Gipson D, Michailidis G, Pennathur S, Michigan Kidney Translational Core CIG (2018) Impaired beta-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J Am Soc Nephrol 29(1):295–306. https://doi.org/10.1681/ASN.2017030350

Aflaki E, Radovic B, Chandak PG, Kolb D, Eisenberg T, Ring J, Fertschai I, Uellen A, Wolinski H, Kohlwein SD, Zechner R, Levak-Frank S, Sattler W, Graier WF, Malli R, Madeo F, Kratky D (2011) Triacylglycerol accumulation activates the mitochondrial apoptosis pathway in macrophages. J Biol Chem 286(9):7418–7428. https://doi.org/10.1074/jbc.M110.175703

Santamarina-Fojo S, Hoeg JM, Assmann G, Brewer HB (2001) Lecithin cholesterol acyltransferase deficiency and fish eye disease. The metabolic and molecular bases of inherited diseases. McGraw-Hill:New York. NY, USA 2001:2817–2833. https://doi.org/10.1036/ommbid.147

Holleboom AG, Kuivenhoven JA, van Olden CC, Peter J, Schimmel AW, Levels JH, Valentijn RM, Vos P, Defesche JC, Kastelein JJ, Hovingh GK, Stroes ES, Hollak CE (2011) Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase. Atherosclerosis 216(1):161–165. https://doi.org/10.1016/j.atherosclerosis.2011.01.025

Article  CAS  PubMed  Google Scholar 

Pavanello C, Ossoli A, Arca M, D’Erasmo L, Boscutti G, Gesualdo L, Lucchi T, Sampietro T, Veglia F, Calabresi L (2020) Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort. J Lipid Res 61(12):1784–1788. https://doi.org/10.1194/jlr.P120000976

Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, Franceschini G (2005) The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25(9):1972–1978. https://doi.org/10.1161/01.ATV.0000175751.30616.13

Article  CAS  PubMed  Google Scholar 

Boscutti G, Calabresi L, Pizzolitto S, Boer E, Bosco M, Mattei PL, Martone M, Milutinovic N, Berbecar D, Beltram E, Franceschini G (2011) [LCAT deficiency: a nephrological diagnosis]. G Ital Nefrol 28(4):369–382

PubMed  Google Scholar 

Borysiewicz LK, Soutar AK, Evans DJ, Thompson GR, Rees AJ (1982) Renal failure in familial lecithin: cholesterol acyltransferase deficiency. Q J Med 51(204):411–426

CAS  PubMed  Google Scholar 

Imbasciati E, Paties C, Scarpioni L, Mihatsch MJ (1986) Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes. Am J Nephrol 6(1):66–70. https://doi.org/10.1159/000167056

Ossoli A, Neufeld EB, Thacker SG, Vaisman B, Pryor M, Freeman LA, Brantner CA, Baranova I, Francone NO, Demosky SJ Jr., Vitali C, Locatelli M, Abbate M, Zoja C, Franceschini G, Calabresi L, Remaley AT (2016) Lipoprotein X causes renal disease in LCAT deficiency. PLoS One 11(2):e0150083. https://doi.org/10.1371/journal.pone.0150083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomaraschi M, Turri M, Strazzella A, Lhomme M, Pavanello C, Le Goff W, Kontush A, Calabresi L, Ossoli A (2023) Abnormal lipoproteins trigger oxidative stress-mediated apoptosis of renal cells in LCAT deficiency. Antioxidants. https://doi.org/10.3390/antiox12081498

Article  PubMed  PubMed Central  Google Scholar 

Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEldrew D, Nassur JA, Rand EB, Krock BL, Kamath BM, Krantz ID, Piccoli DA, Loomes KM, Spinner NB (2019) Alagille syndrome mutation update: comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. Hum Mutat 40(12):2197–2220. https://doi.org/10.1002/humu.23879

Habib R, Dommergues JP, Gubler MC, Hadchouel M, Gautier M, Odievre M, Alagille D (1987) Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1(3):455–464. https://doi.org/10.1007/BF00849254

Davis J, Griffiths R, Larkin K, Rozansky D, Troxell M (2010) Glomerular basement membrane lipidosis in Alagille syndrome. Pediatr Nephrol 25(6):1181–1184. https://doi.org/10.1007/s00467-009-1426-0

Ayoub MD, Kamath BM (2022) Alagille syndrome: current understanding of pathogenesis, and challenges in diagnosis and management. Clin Liver Dis 26(3):355–370. https://doi.org/10.1016/j.cld.2022.03.002

Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E (2020) Apolipoprotein E-related glomerular disorders. Kidney Int 97(2):279–288. https://doi.org/10.1016/j.kint.2019.10.031

Matsunaga A, Saito T (2025) Impact of apolipoprotein E variants: a review of naturally occurring variants and clinical features. J Atheroscler Thromb 32(3):281–303. https://doi.org/10.5551/jat.65393

Kawanishi K, Sawada A, Ochi A, Moriyama T, Mitobe M, Mochizuki T, Honda K, Oda H, Nishikawa T, Nitta K (2013) Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature. Case Rep Nephrol Urol 3(2):128–135. https://doi.org/10.1159/000356849

Katsarou M, Stratikos E, Chroni A (2018) Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy. J Lipid Res 59(12):2339